IL223481B - Insert comprising misoprostol and a cross-linked reaction product of a diisocyanate, a triol and a polyethylene glycol for intravaginal administration in a nulliparous female - Google Patents

Insert comprising misoprostol and a cross-linked reaction product of a diisocyanate, a triol and a polyethylene glycol for intravaginal administration in a nulliparous female

Info

Publication number
IL223481B
IL223481B IL223481A IL22348112A IL223481B IL 223481 B IL223481 B IL 223481B IL 223481 A IL223481 A IL 223481A IL 22348112 A IL22348112 A IL 22348112A IL 223481 B IL223481 B IL 223481B
Authority
IL
Israel
Prior art keywords
misoprostol
triol
diisocyanate
insert
cross
Prior art date
Application number
IL223481A
Other languages
English (en)
Hebrew (he)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL223481B publication Critical patent/IL223481B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
IL223481A 2010-06-11 2012-12-06 Insert comprising misoprostol and a cross-linked reaction product of a diisocyanate, a triol and a polyethylene glycol for intravaginal administration in a nulliparous female IL223481B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35383510P 2010-06-11 2010-06-11
PCT/US2011/040202 WO2011156812A2 (fr) 2010-06-11 2011-06-13 Administration intravaginale de misoprostol

Publications (1)

Publication Number Publication Date
IL223481B true IL223481B (en) 2018-11-29

Family

ID=45098734

Family Applications (1)

Application Number Title Priority Date Filing Date
IL223481A IL223481B (en) 2010-06-11 2012-12-06 Insert comprising misoprostol and a cross-linked reaction product of a diisocyanate, a triol and a polyethylene glycol for intravaginal administration in a nulliparous female

Country Status (18)

Country Link
US (1) US20130197081A1 (fr)
EP (1) EP2579866B1 (fr)
JP (2) JP5964294B2 (fr)
KR (1) KR101852913B1 (fr)
CN (1) CN102939085B (fr)
AU (1) AU2011265222B2 (fr)
CA (1) CA2802214A1 (fr)
DK (1) DK2579866T3 (fr)
ES (1) ES2587260T3 (fr)
HK (1) HK1184059A1 (fr)
HU (1) HUE028795T2 (fr)
IL (1) IL223481B (fr)
MX (1) MX339883B (fr)
NZ (1) NZ604064A (fr)
PL (1) PL2579866T3 (fr)
PT (1) PT2579866T (fr)
RU (1) RU2588671C2 (fr)
WO (1) WO2011156812A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2579866B1 (fr) * 2010-06-11 2016-05-18 Ferring B.V. Administration intravaginale de misoprostol
CN102302443B (zh) * 2011-09-21 2014-04-23 天津市聚星康华医药科技有限公司 一种米索前列醇阴道缓释栓剂及其制备方法
EP2689802A1 (fr) 2012-07-26 2014-01-29 Ferring B.V. Formulation de misoprostol
EP2754443A1 (fr) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol pour le déclenchement de l'accouchement
EP2689781A1 (fr) 2012-07-26 2014-01-29 Ferring B.V. Composition de misoprostol
MX2015001007A (es) * 2012-07-26 2015-04-09 Ferring Bv Composicion de misoprostol.
JP2015522645A (ja) * 2012-07-26 2015-08-06 フェリング ベスローテン フェンノートシャップ ミソプロストール処方物
EP2754442A1 (fr) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol pour le déclenchement de l'accouchement
NZ727876A (en) 2014-07-11 2018-05-25 Azanta Danmark As Misoprostol dispersible tablet
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
US20190298735A1 (en) * 2016-07-08 2019-10-03 Vanderbilt University Treatment and prevention of clostridium difficile colitis using misoprostol
CN108753898A (zh) * 2018-04-09 2018-11-06 深圳市祥根生物科技有限公司 一种米索前列醇酸的制备方法及其用途
EP3935581A4 (fr) 2019-03-04 2022-11-30 Iocurrents, Inc. Compression et communication de données à l'aide d'un apprentissage automatique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017382A (en) * 1979-03-21 1991-05-21 National Research Development Corporation Controlled release compositions (II)
US20020031513A1 (en) * 1997-11-24 2002-03-14 Shamir Leibovitz Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006089561A1 (fr) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Compositions pharmaceutiques contenant des acides organiques utiles pour le ramollissement et la maturation du col de l’uterus.
US20090269480A1 (en) * 2008-04-24 2009-10-29 Medtronic Vascular, Inc. Supercritical Fluid Loading of Porous Medical Devices With Bioactive Agents
WO2010036878A1 (fr) * 2008-09-26 2010-04-01 The Trustees Of Columbia University In The City Of New York Utilisation des agonistes du récepteur trpv1 dans le cadre de la douleur cervicale et du travail
RU2408375C1 (ru) * 2009-06-04 2011-01-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта Северо-Западного отделения РАМН Способ подготовки к родам беременных с преждевременным излитием околоплодных вод при доношенном сроке
EP2579866B1 (fr) * 2010-06-11 2016-05-18 Ferring B.V. Administration intravaginale de misoprostol

Also Published As

Publication number Publication date
NZ604064A (en) 2014-10-31
RU2012154445A (ru) 2014-07-20
EP2579866B1 (fr) 2016-05-18
CN102939085A (zh) 2013-02-20
DK2579866T3 (en) 2016-08-29
CA2802214A1 (fr) 2011-12-15
KR101852913B1 (ko) 2018-04-27
JP2016164167A (ja) 2016-09-08
HK1184059A1 (zh) 2014-01-17
RU2588671C2 (ru) 2016-07-10
US20130197081A1 (en) 2013-08-01
MX339883B (es) 2016-06-16
MX2012014413A (es) 2013-02-26
KR20130109099A (ko) 2013-10-07
CN102939085B (zh) 2016-05-04
WO2011156812A3 (fr) 2012-04-19
JP2013528231A (ja) 2013-07-08
EP2579866A4 (fr) 2013-12-04
AU2011265222B2 (en) 2015-04-02
PL2579866T3 (pl) 2017-01-31
WO2011156812A2 (fr) 2011-12-15
AU2011265222A1 (en) 2013-05-23
ES2587260T3 (es) 2016-10-21
JP6262787B2 (ja) 2018-01-17
PT2579866T (pt) 2016-08-19
JP5964294B2 (ja) 2016-08-03
HUE028795T2 (en) 2017-01-30
EP2579866A2 (fr) 2013-04-17

Similar Documents

Publication Publication Date Title
IL223481B (en) Insert comprising misoprostol and a cross-linked reaction product of a diisocyanate, a triol and a polyethylene glycol for intravaginal administration in a nulliparous female
HUS2200018I1 (hu) Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra
HK1215666A1 (zh) 藥劑儲存、分配和給藥系統與方法
EP2579822B8 (fr) Système de pose d'endoprothèse bidirectionnel
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
EP2605698A4 (fr) Photopléthysmographie de site central, administration de médicament et sécurité
EP2585019A4 (fr) Dispositif de protection contre l'incontinence masculine
EP2563338A4 (fr) Application à cisaillement élevé utilisée pour l'administration de médicament
WO2012125772A3 (fr) Formulations orales pour promotion de purification cellulaire
EP2586462A4 (fr) Agent prophylactique ou d'amélioration pour maladies génétiques
EP2612914A4 (fr) Oligonucléotide, et agent thérapeutique pour la dyslipidémie contenant l'oligonucléotide comme ingrédient actif
EP2777713A4 (fr) Conjugué médicamenteux de polyéthylèneglycol-oligopeptide d'acides aminés-irinotécan et composition médicamenteuse de celui-ci
EP2552426A4 (fr) Dispositif d'administration de médicaments intravaginal
EP2790637A4 (fr) Dispositifs d'administration de médicaments vaginaux et procédés de fabrication de ceux-ci
EP2646042A4 (fr) Agent cytotoxique envers les tumeurs et méthodes associées
EP2729926A4 (fr) Système et procédé d'administration d'évaluation sans fil
PT2533758E (pt) Grânulo farmacêutico de fator de crescimento epidérmico administrável oralmente
MX2015001008A (es) Formulacion de misoprostol.
GB201007547D0 (en) Stoma care station
HK1171919A1 (zh) 含有耐磨性和潤滑性添加劑的粒狀磷酸二氫鈣產品
EP2858689A4 (fr) Polyéther uréthane et polyéther urée basée sur des copolymères et procédés associés
GB2476146B (en) Pharmaceutical product storage and delivery system
RS20110018A3 (en) COMBINED TABLET FORM AND PROCEDURES FOR ITS OBTAINING IT
GB201005712D0 (en) Medicaments and their manufacture
GB201000390D0 (en) Dressing for a male catheter

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees